首页> 外文期刊>Neuropathology: official journal of the Japanese Society of Neuropathology >Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats
【24h】

Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats

机译:S-100β-v-erbB转基因大鼠中神经胶质瘤中小胶质细胞/巨噬细胞的特征

获取原文
获取原文并翻译 | 示例
       

摘要

Glioma-infiltrating microglia/macrophages are referred to as tumor-associated macrophages (TAMs). Transgenic (TG) rats expressing v-erbB, which is a viral form of the epidermal growth factor receptor, under transcriptional regulation by the S100-β promoter, develop brain tumors. This study was designed to clarify the pathological characteristics of TAMs in these experimental tumors. We carried out immunohistochemical and morphometrical analyses of microglia/macrophages in brain tumors (5 malignant glioma, 4 anaplastic oligodendroglioma, 4 astrocytoma) that developed in TG rats. TAMs with ionized calcium-binding adaptor molecule 1 (Iba1) positivity and morphology of activated, non-phagocytic microglia increased within and around the tumors in malignant gliomas and anaplastic astrocytomas. The Iba1-positive TAMs of the tumor core were significantly more activated than Iba1-positive microglia of non-neoplastic brain tissue in intraparenchymal anaplastic oligodendrogliomas. Iba1 expression showed a significant positive correlation to Ki-67 expression in all the gliomas. Most TAMs showed no or little expression against CD68, CD163 or CD204, although CD204-positive TAMs were observed in necrosis as well as in the proliferating vascular wall. In conclusion, S-100β-v-erbBTG rats may serve as a useful animal model for further analysis of TAMs in terms of tumor cell proliferation, microvascular proliferation and phagocytosis, and as a tool for therapeutic use in malignant gliomas, although it should be noted that the polarization of TAMs toward the M2 phenotype remains unclear.
机译:胶质瘤浸润的小胶质细胞/巨噬细胞被称为肿瘤相关巨噬细胞(TAM)。在S100-β启动子的转录调控下,表达v-erbB(表皮生长因子受体的一种病毒形式)的转基因(TG)大鼠发展为脑瘤。本研究旨在阐明这些实验性肿瘤中TAM的病理特征。我们对在TG大鼠中发展的脑肿瘤(5个恶性神经胶质瘤,4个间变性少突胶质神经胶质瘤,4个星形细胞瘤)中的小胶质细胞/巨噬细胞进行了免疫组织化学和形态计量学分析。具有恶性神经胶质瘤和间变性星形细胞瘤的肿瘤内和周围,具有离子化钙结合衔接子分子1(Iba1)阳性和活化,非吞噬性小胶质细胞形态的TAM增多。在实质性间变性间变性少突胶质细胞瘤中,肿瘤核心的Iba1阳性TAM比非肿瘤性脑组织的Iba1阳性小胶质细胞活化得多。在所有神经胶质瘤中,Iba1表达均与Ki-67表达显着正相关。尽管在坏死以及增生的血管壁中都观察到了CD204阳性TAM,但大多数TAM对CD68,CD163或CD204却没有或几乎没有表达。总之,S-100β-v-erbBTG大鼠可作为进一步分析肿瘤细胞增殖,微血管增殖和吞噬作用的TAM的有用动物模型,并且可作为治疗恶性神经胶质瘤的工具,尽管应该注意到,TAM向M2表型的极化仍然不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号